“Low eosinophil” biomarkers found in nearly three-quarters of people with mild persistent asthma A study of nearly 300 patients with mild persistent asthma found that inhaled steroids— long considered the gold standard for asthma treatment —were no more effective than placebo in nearly three-fourths of the study patients, all over age 12. Inhaled...
Two recent NHLBI-funded studies have found a particularly worrisome link between stress and increased risk of cardiovascular disease, which includes heart disease and stroke, in African Americans.
Clare M. Waterman, Ph.D., NIH distinguished investigator and director of the NHLBI Laboratory of Cell and Tissue Morphodynamics has been elected to the National Academy of Sciences (NAS), the highest honor for American scholars in recognition of their distinguished and continuing achievements in ori
True or false: People can get by on five or fewer hours of sleep.
In the largest study to date to explore how young doctors spend their work day, researchers are reporting that first-year doctors spend almost 90 percent of their time away from patients.
New mouse model could speed development of effective treatments for most common form of heart failure
Researchers are reporting development of a new mouse model that could speed development of effective treatments for the most common form of heart failure.
Targeting a seldom-used DNA repair pathway with gene editing could be a strategy to treat rare diseases
Researchers developed a gene editing strategy to repair parts of the DNA affected by microduplications. These small segments of DNA, when copied or duplicated, can ultimately lead to loss of function of the protein and over 100 different rare diseases.
A study revealed that certain amounts of glucose, or sugar, is important for the lung immune system to function properly in mice.
Researchers partially funded by NHLBI have discovered that a reaction in the gut informs the brain that it should switch the neurons that indicate thirst on or off.
Researchers have optimized CRISPR-Cas9 technology, a gene editing approach revolutionizing medical research, to achieve therapeutic editing of the blood stem cell population.
Researchers have developed bioengineered blood vessels that closely mimic the structure and function of human blood vessels and show promise of being safer and more effective than current grafts made of synthetic materials.